A recent survey of more than 12,000 patients and their friends and family found that the public sees clinical trial research as important, but doesn’t know much about the research process, and sees trial participation as burdensome. Federal agencies are actively exploring ways to make drug development more patient-focused, which could reduce the burden of participation and encourage greater trial enrollment. (Business Insider)